Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Article and Video CATEGORIES
CO1686 - 3rd Generation Drug for Acquired Resistance in EGFR Lung Cancer
Lung cancer patients with the EGFR mutation who had progressed on other drugs did well on a new drug in clinical trial, though one particular side effect concerns some.
[powerpress]
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Video
En este video, la Dra. Velázquez Mañana analiza las mutaciones del EGFR, los diferentes subtipos de cáncer de pulmón y cómo determinar cuál es el mejor tratamiento en general.
To watch the complete playlist, click here.
Special thanks to Genentech, BMS, TakedaJohnson & Johnson, and Daiichi-Sankyo for their sponsorship of this program.
Article
Head and neck cancers linked to human papillomavirus (HPV) are very different from those caused by tobacco or alcohol. The good news is that HPV-positive cancers usually respond better to treatment and often have better outcomes.
Image
Article
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial. We want to hear from you!